2022-08-19
Student? Take the opportunity to join the front lines to act on antimicrobial resistance and COVID-19 in the Innovate4Health competition. This year, student teams are encouraged to innovate around three pillars: prevention and treatment, reduce use of antimicrobials in food systems and resilient community health systems. Deadline is 19 September.
The competition is organized by the ReAct, the International Federation of Medical Students’ Associations (IFMSA), and the IDEA (Innovation + Design Enabling Access) Initiative at the Johns Hopkins Bloomberg School of Public Health.
In focus: Social innovation in low resource settings
Taking a systems approach, Innovate4Health emphasizes social innovations that consider the needs of resource-limited settings. We are looking for student teams (2-5 students per team) with ideas for innovative solutions and an interest in continuing to develop and refine their ideas in a design sprint curriculum.
Through the design sprint, teams will work through:
- ideation
- implementation
- advocacy strategies
to support the adoption of these approaches.
The design sprint activities are developed from year to year – to strengthen the value for participating teams. This year’s cohort will have the opportunity to:
- develop stage-specific strategies
- write a blog advancing the social mission behind the team’s innovation
- prepare a poster presentation of their project
- put together a social media advocacy piece
Innovate around 3 pillars
This year, student teams are encouraged to innovate around one of three pillars:
- Ensuring effective prevention and treatment of emerging infectious diseases in the healthcare delivery system
- Reducing the use and the need to use antimicrobials in food systems
- Making community health systems more resilient to emerging infectious diseases
Coached by experts
A group of experts will coach the team on its final presentation, which will be shared as a recording. The selected teams will work with a team of experts and coaches to co-construct their solutions through both recorded and live learning sessions. We invite applications from teams that would be excited to collaborate with other highly talented student teams.
The design sprint will extend from October 2022 through January 2023.
Looking for innovative student teams with a vision
Students do not need any previous experience involving antimicrobial resistance or other emerging infectious diseases. In the competitive application process, we are looking for student teams providing a vision for what they might want to innovate, including the specific problem and context, as well as sharing how they might be positioned to help implement such a project.
Application: not fully developed projects
At the application stage, however, we do not expect fully developed projects. The design sprint process is intended to help teams develop further their ideas from the application stage.
More information
You can find additional information on the Innovate4Health website.
There you can find:
- more background information on Innovate4Health
- the design sprint timeline
- terms and conditions
- submission guidelines
Last year, over 70 student teams answered our call for Innovate4AMR applications, and only 15 finalist teams were selected.
Deadline team applications: Monday, September 19, 2022.
Sign up for updates: We will be releasing additional resources to support teams in developing applications, and interested students can sign up for updates.
More from "2022"
- 15 things that need to happen in 2023 – for a robust response on antibiotic resistance!
- 7.7 million people die from bacterial infections every year
- ReAct highlights during World Antimicrobial Awareness Week 2022
- Awareness walk in Lusaka, Zambia
- ReAct Asia Pacific: Competitions, webinars, social media campaigns and new Indonesian declaration on AMR
- Otto Cars awarded Research!Sweden’s Honorary Award
- Innovate4Health: 16 finalists from 12 countries!
- Otto Cars has dedicated his life to the fight against antibiotic resistance
- ReAct activities for World Antimicrobial Awareness Week 2022
- ReAct Asia Pacific: Antibiotic Smart Communities as a way forward
- Webinar ReAct Asia Pacific! Moving towards an Antibiotic Smart Community – the use of a novel indicator framework
- Join ReAct Latin America Meeting: Empowered Communities!
- The impact of antibiotic resistance on cancer treatment, especially in low-and middle-income countries, and the way forward
- Sweden: Pernilla’s 8-day old daughter died from sepsis – caused by resistant bacteria Klebsiella
- Five challenges that governments need to address in resolving the stagnation in antibiotic development
- The monkeypox outbreak: Need for antibiotic stewardship?
- Key takeaways from the ReAct Africa and South Centre Conference
- New ReAct Europe and EPHA position paper on EU incentives for new antibiotics development
- Launch of a new approach to antimicrobial stewardship in Zambia
- Time to register for the annual ReAct Africa and South Centre conference!
- Innovate4Health 2022: Call for student team applications!
- “Need to address the paradox of hospitals spreading disease” says new WHO report
- 5 takeaways from AMR Stockholm+50 event
- Student Tehseen Contractor
- ReAct Latin America: call to governments on the use of antimicrobials in intensive animal husbandry
- Join ReAct Stockholm+50 associated event! Global AMR response – What needs to be done?
- New opportunities for global action on AMR?
- Public hearings on elements to be included in a new international instrument on pandemic preparedness & response
- Policy briefing on WHO GAP AMR: 8 pillars of action to address global solutions to AMR
- India: State Action Plans on AMR in focus at stakeholder colloquium
- The silence is killing us – time to listen to the facts
- Access to clean water – a fairly inexpensive way to avoid infections
- Anna Sjöblom new Director ReAct Europe
- Dr. Hari Paraton: Drug resistance bacteria threatens lives of mothers and newborns
- Antibiotic resistance claims more than 1,2 million lives a year, says new large study
- Artificial intelligence – the future of antibiotic resistance prevention?